Profile data is unavailable for this security.
About the company
Pharmena SA is a Poland-based producer of cosmetics and pharmaceuticals. The Company’s products range encompasses Dermena, a line of products against hair loss; Dermena Plus, a shampoo reducing the symptoms of dandruff and preventing excessive hair loss; Accos, an anti-acne gel; Allerco, a line of hypo-allergic emollients for body care, Thermi, a gel after thermal burn and sunburn; and Revium, a line of anti-wrinkle treatment products. Pharmena SA maintains multidirectional research works and application studies in conjunction with a number of research centers in Europe, the United States and Canada. As of December 31, 2011, the Company had one wholly owned subsidiary, Cortria Corporation, based in the United States. As of December 31, 2011, Polska Grupa Farmaceutyczna SA held a 43.65% stake in the capital. The main shareholder of the Company is Pelion SA.
- Revenue in PLN (TTM)291.00k
- Net income in PLN28.98m
- Incorporated2008
- Employees15.00
- LocationPharmena SAul. Wolczanska 178LODZ 90-530PolandPOL
- Phone+48 422913370
- Fax+48 422913371
- Websitehttps://www.pharmena.eu/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Photocat A/S | 7.69m | -1.14m | 24.37m | 11.00 | -- | 3.29 | -- | 3.17 | -0.5097 | -0.5097 | 3.32 | 3.29 | 0.5576 | 1.90 | 3.00 | 2,924,573.00 | -8.28 | -13.93 | -10.52 | -17.04 | 86.97 | 77.01 | -14.84 | -20.91 | 1.03 | -2.21 | 0.1193 | -- | 1.36 | 26.81 | 35.69 | -- | 24.01 | -- |
| Harper Hygienics SA | -100.00bn | -100.00bn | 33.75m | 584.00 | -- | 0.5332 | -- | -- | -- | -- | -- | 9.94 | -- | -- | -- | -- | -- | -0.7789 | -- | -1.45 | -- | 22.20 | -- | -0.8215 | 0.8666 | -- | 0.609 | -- | 5.54 | -- | 104.34 | -- | -- | -- |
| 4Mass SA | 103.73m | 17.45m | 34.05m | 103.00 | 9.49 | 2.57 | 1.68 | 0.3282 | 0.7268 | 0.7268 | 4.32 | 2.68 | 1.37 | 1.30 | 11.93 | 1,007,106.00 | 23.00 | 17.26 | 26.30 | 20.61 | 61.26 | 54.32 | 16.82 | 12.20 | 1.49 | 31.85 | 0.0479 | -- | 51.79 | 57.43 | 113.18 | 101.58 | -- | -- |
| Brand Architekts Group PLC | 88.89m | -7.60m | 40.84m | 45.00 | -- | 0.3164 | -- | 0.4595 | -0.0521 | -0.0521 | 0.6093 | 0.8851 | 0.5318 | 1.85 | 3.56 | 378,377.80 | -4.34 | -9.44 | -4.98 | -10.88 | 41.22 | 35.10 | -8.16 | -22.40 | 3.62 | -- | 0.00 | -- | -15.23 | -2.85 | 77.90 | -- | -52.55 | -- |
| Clemondo Group AB (publ) | 97.99m | 2.50m | 42.88m | 56.00 | 17.18 | 1.01 | 5.21 | 0.4376 | 0.048 | 0.048 | 1.88 | 0.8188 | 1.35 | 3.65 | 7.16 | 5,112,922.00 | 3.45 | 6.57 | 5.28 | 11.12 | 37.22 | 38.86 | 2.55 | 4.38 | 0.6238 | 12.65 | 0.1292 | 0.00 | -6.79 | 0.7884 | 164.56 | -- | -24.33 | -- |
| Miraculum SA | 48.27m | -1.59m | 45.60m | 54.00 | -- | 1.42 | -- | 0.9446 | -0.0367 | -0.0367 | 1.15 | 0.6743 | -- | -- | -- | 893,973.50 | -- | -5.49 | -- | -7.50 | 35.85 | 32.61 | -3.29 | -8.88 | 0.4959 | 0.4549 | 0.2712 | -- | 8.66 | 16.18 | 33.44 | -- | -11.53 | -- |
| Pharmena SA | 291.00k | 28.98m | 56.13m | 15.00 | 1.94 | 4.54 | 1.93 | 192.90 | 2.60 | 2.60 | 0.0261 | 1.11 | 0.0089 | 0.5832 | 0.1295 | 19,400.00 | 88.31 | 1.11 | 1,064.19 | 5.11 | 27.15 | 55.39 | 9,958.08 | 1.87 | 11.31 | -- | 0.0125 | -- | 0.00 | -53.00 | 628.36 | -- | -6.78 | -- |
| Lifeclean International AB (publ) | 24.47m | -20.71m | 58.52m | -- | -- | 15.73 | -- | 2.39 | -1.05 | -1.05 | 1.23 | 0.178 | 0.8852 | 2.70 | 8.80 | -- | -74.93 | -41.90 | -157.53 | -61.79 | 43.29 | 51.08 | -84.65 | -67.57 | 0.7171 | -16.09 | 0.7975 | -- | 11.28 | 83.22 | -22.59 | -- | 15.00 | -- |
| Aqua Bio Technology ASA | 26.73m | -16.47m | 67.63m | 4.00 | -- | 1.41 | -- | 2.53 | -0.9554 | -0.9554 | 1.46 | 1.95 | 0.4038 | 2.30 | 2.43 | 18,064,300.00 | -24.88 | -34.43 | -50.93 | -60.27 | 43.81 | 42.16 | -61.61 | -306.49 | 0.4165 | -4.03 | 0.4244 | -- | 162.31 | 83.77 | -12.21 | -- | 31.45 | -- |
| Creightons plc | 277.69m | -18.41m | 100.03m | 407.00 | -- | 0.8688 | -- | 0.3602 | -0.052 | -0.052 | 0.7286 | 0.3223 | 1.30 | 3.29 | 4.64 | 130,697.80 | -8.64 | 4.15 | -11.83 | 5.88 | 42.92 | 41.97 | -6.63 | 2.69 | 1.46 | 4.36 | 0.1509 | 19.88 | -9.17 | 3.85 | -786.19 | -- | -17.69 | -3.93 |
| Delko SA | 882.32m | 15.21m | 114.82m | 1.15k | 7.55 | 0.7183 | 3.57 | 0.1301 | 1.27 | 1.27 | 73.77 | 13.37 | 2.52 | 0.1638 | 10.53 | 769,916.30 | 4.34 | -- | 7.48 | -- | 98.30 | -- | 1.72 | -- | 0.7472 | 556.19 | 0.3919 | -- | -- | -- | -- | -- | -- | -- |
| Viking Kagit ve Seluloz A.S. | 113.83m | 971.34k | 144.21m | 179.00 | 148.47 | 6.73 | 13.46 | 1.27 | 0.194 | 0.194 | 22.73 | 4.28 | 0.61 | 8.06 | 10.62 | 4,750,206.00 | 0.5206 | -4.60 | 2.53 | -17.13 | 2.43 | 8.63 | 0.8533 | -5.96 | 0.1376 | -0.5105 | 0.8824 | -- | -37.08 | 32.11 | -246.60 | -- | 34.36 | -- |
Data as of Nov 13 2024. Currency figures normalised to Pharmena SA's reporting currency: Polish New Zloty PLN
0.00%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Norges Bank Investment Managementas of 30 Jun 2024 | 0.00 | 0.00% |
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
